Independent directors not immune from antitrust scrutiny as crackdown on interlocking directorates continues, DOJ official says
Independent directors appointed to company boards by private equity firms shouldn’t consider themselves immune from scrutiny and action as the US Department of Justice continues its antitrust crackdown on interlocking directorates,...To view the full article, register now.
Already a subscriber? Click here to view full article